Investor FAQs


Tempest and Millendo have announced a merger.


Investor FAQs

Show All
Who is Millendo Therapeutics?

Millendo Therapeutics is a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases. We create distinct and transformative treatments for endocrine diseases where there is a significant unmet medical need.

Where is Millendo Therapeutics corporate headquarters?
Millendo Therapeutics’ corporate headquarters are located at 110 Miller Ave., Suite 100 Ann Arbor, MI 48104. The main office phone number is (734) 845-9000.
Where is the company incorporated?
What is Millendo Therapeutics’ fiscal year?
December 31.
Where is Millendo Therapeutics’ stock traded and what is the stock symbol?
Millendo Therapeutics’ common stock is traded on the Nasdaq Capital Market under the symbol MLND.
Does Millendo Therapeutics’ pay dividends?
Millendo Therapeutics does not anticipate paying any cash dividends in the foreseeable future.
Who is Millendo Therapeutics’ transfer agent?

The transfer agent and registrar for Millendo Therapeutics’ common stock is:

Computershare Trust Company, N.A.
P.O. Box 43078
Providence, RI 02940

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

All questions regarding ownership of Millendo Therapeutics’ common stock should be addressed to the appropriate transfer agent:

Computershare Trust Company, N.A.
P.O. Box 43078
Providence, RI 02940

Does Millendo Therapeutics have a direct stock purchase plan?
Millendo Therapeutics does not offer a direct stock purchase plan.
Who is Millendo Therapeutics’ independent accountants?
Ernst & Young
171 Monroe Ave NW # 600
Grand Rapids, MI, 49503
Who is Millendo Therapeutics’ legal counsel?
Cooley LLP
500 Boylston Street
Boston, MA 02116-3736
Where can I find more information about Millendo Therapeutics, including its SEC filings?
Our website is the best place; located at The investor section contains all the latest press releases and SEC filings.
How do I obtain further information or materials on Millendo Therapeutics?
For general inquiries, please contact For media requests, please contact
How can I receive email updates about Millendo Therapeutics?
Please sign up for alerts using the button at the bottom of this page.
Who should I contact regarding investor inquiries?

Investor inquiries should be directed to or 734-845-9000.